Cornerstone Select Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Cornerstone Select Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.13M	Sell	18,607 -1,963	-10%	-$114K	0.71%	47
2025 Q4	$1.11M	Sell	20,570 -2,546	-11%	-$122K	0.77%	44
2025 Q3	$1.04M	Sell	23,116 -5,376	-19%	-$251K	0.77%	45
2025 Q2	$1.32M	Sell	28,492 -686	-2%	-$33.7K	1.16%	32
2025 Q1	$1.78M	Buy	29,178 +568	+2%	+$33.1K	1.69%	17
2024 Q4	$1.62M	Buy	+28,610	New	+$1.6M	1.56%	20

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cornerstone Select Advisors's BMY Position: Q1 2026 in Review

Cornerstone Select Advisors reduced its Bristol-Myers Squibb (BMY) stake by 9.5% in Q1 2026, selling an estimated $114K and leaving 18,607 shares worth $1.13M. The position accounts for 0.71% of the portfolio, ranked #47.

Cornerstone Select Advisors first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.78M in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Cornerstone Select Advisors held 18,607 shares of Bristol-Myers Squibb worth $1.13M as of Q1 2026.
Cornerstone Select Advisors sold 1,963 Bristol-Myers Squibb shares in Q1 2026, an estimated $114K.
Bristol-Myers Squibb made up 0.71% of Cornerstone Select Advisors's portfolio in Q1 2026, its #47 holding.
Cornerstone Select Advisors first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
Cornerstone Select Advisors's Bristol-Myers Squibb position peaked at $1.78M in Q1 2025.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Cornerstone Select Advisors's 13F filing for Q1 2026, filed 13 May 2026.